Is Vigabatrin the same as vigabatrin?

The main active ingredient of Vigabatrin is vigabatrin (gamma-Vinyl GABA, abbreviated as GVG), it is a γ-aminobutyric acid (GABA) analog. As an anti-epileptic drug, vigabatrin exerts depressant effects in the nervous system through a unique mechanism of action. It increases GABA concentration in the brain by irreversibly inhibiting the activity of GABA transaminase (GABA-T), thereby helping to inhibit abnormal firing of neurons and reducing the frequency and intensity of epileptic seizures.

Due to its mechanism of action, vigabatrin has shown good efficacy in the treatment of refractory epilepsy, especially infantile spasms (West syndrome). Unlike traditional anti-epileptic drugs, vigabatrin does not directly act on synapses, but indirectly reduces abnormal activity of neurons by increasing the levels of the inhibitory neurotransmitter GABA in the brain. This mechanism is particularly effective for some types of epilepsy in which other drugs are ineffective.

However, the use of vigabatrin also comes with side effects, most notably visual impairment, which may lead to visual field defects. This is because its mechanism irreversibly affectsGABAaminase, so patients must have regular vision checks during the use of vigabatrin to detect possible adverse reactions early. In addition, patients may experience side effects such as drowsiness, headache, and weight gain, and must use it under the guidance of a doctor.

In general, Vigabatrin, as a preparation of vigabatrin, provides an important treatment option for patients with refractory epilepsy, but it must be used with caution and medical advice must be strictly followed to ensure the safety and effectiveness of the medication.